Sector Update: Health Care


Shutterstock photo

Healthcare stocks were ending narrowly mixed with the NYSE Healthcare Sector Index advancing about 0.1% and shares of healthcare companies in the S&P 500 sinking less than 0.1% as a group.

In company news, Cancer Genetics Inc. ( CGIX ) advanced Wednesday after the National Institutes of Health added the company's genomic-diagnostic tests to its Genetic Testing Registry.

Inclusion on the registry extends access to a broader audience of clinicians, oncologists, patients and other biopharma companies to information about CGIX's proprietary genomic tests as well as its non-proprietary test offerings, it said.

CGIX shares were up more about 7.3% at $9.39 each, well off their session high of $10.24 a share earlier today. The stock has traded within a 52-week range of $8.48 to $23.25 a share, falling nearly 11% over the past 12 months.

In other sector news,

(+) BSPM, Hires Xiaohui Zheng - currently a professor and the director of the Engineering Research Center for the modernization of Chinese herbal medicine at Northwestern University - as its chief scientist and guiding its product development.

(-) ALNY, U.S. Patent and Trademark Office issues Notice of Allowance for the company's patent application for compositions using a double-stranded molecule of between 19 and 52 nucleotides in each strand.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: CGIX

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by